These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1670992)

  • 21. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization of blood coagulation factors in situ in pancreatic carcinoma.
    Wojtukiewicz MZ; Rucinska M; Zacharski LR; Kozlowski L; Zimnoch L; Piotrowski Z; Kudryk BJ; Kisiel W
    Thromb Haemost; 2001 Dec; 86(6):1416-20. PubMed ID: 11776308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma.
    Dalal BI; Keown PA; Greenberg AH
    Am J Pathol; 1993 Aug; 143(2):381-9. PubMed ID: 8393616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H; Stephens LC; Kumar R
    Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrin deposition in primary and metastatic human brain tumours.
    Bárdos H; Molnár P; Csécsei G; Adány R
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):536-48. PubMed ID: 8874864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gemfibrozil reduces thrombin generation in patients with combined hyperlipidaemia, without influencing plasma fibrinogen, fibrin gel structure or coagulation factor VII.
    Bröijersén A; Hamsten A; Silveira A; Fatah K; Goodall AH; Eriksson M; Angelin B; Hjemdahl P
    Thromb Haemost; 1996 Aug; 76(2):171-6. PubMed ID: 8865525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
    Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
    Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue.
    Dillon DC; Easley SE; Asch BB; Cheney RT; Brydon L; Jockers R; Winston JS; Brooks JS; Hurd T; Asch HL
    Am J Clin Pathol; 2002 Sep; 118(3):451-8. PubMed ID: 12219788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution of tissue factor pathway inhibitor in normal and malignant human tissues.
    Werling RW; Zacharski LR; Kisiel W; Bajaj SP; Memoli VA; Rousseau SM
    Thromb Haemost; 1993 Apr; 69(4):366-9. PubMed ID: 8497849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In situ analysis of tissue factor-dependent thrombin generation in human atherosclerotic vessels.
    Westmuckett AD; Lupu C; Goulding DA; Das S; Kakkar VV; Lupu F
    Thromb Haemost; 2000 Nov; 84(5):904-11. PubMed ID: 11127875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coexisting macrophage-associated fibrin formation and tumor cell urokinase in squamous cell and adenocarcinoma of the lung tissues.
    Ornstein DL; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Hunt J; Rousseau SM; Stump DC
    Cancer; 1991 Sep; 68(5):1061-7. PubMed ID: 1913476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue transglutaminase expression in human breast cancer.
    Hettasch JM; Bandarenko N; Burchette JL; Lai TS; Marks JR; Haroon ZA; Peters K; Dewhirst MW; Iglehart JD; Greenberg CS
    Lab Invest; 1996 Nov; 75(5):637-45. PubMed ID: 8941210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basal cell-specific and hyperproliferation-related keratins in human breast cancer.
    Wetzels RH; Kuijpers HJ; Lane EB; Leigh IM; Troyanovsky SM; Holland R; van Haelst UJ; Ramaekers FC
    Am J Pathol; 1991 Mar; 138(3):751-63. PubMed ID: 1705754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situ.
    Wojtukiewicz MZ; Zacharski LR; Memoli VA; Kisiel W; Kudryk BJ; Rousseau SM; Stump DC
    Am J Clin Pathol; 1990 Apr; 93(4):516-21. PubMed ID: 1690950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue.
    Monteagudo C; Merino MJ; San-Juan J; Liotta LA; Stetler-Stevenson WG
    Am J Pathol; 1990 Mar; 136(3):585-92. PubMed ID: 2156430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
    Torbet J
    Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
    Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
    Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell cycle control related proteins (p53, p21, and Rb) and transforming growth factor beta (TGFbeta) in benign and carcinomatous (in situ and infiltrating) human breast: implications in malignant transformations.
    García-Tuñón I; Ricote M; Ruiz A; Fraile B; Paniagua R; Royuela M
    Cancer Invest; 2006 Mar; 24(2):119-25. PubMed ID: 16537179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.